Literature DB >> 15476566

Reversible pulmonary hypertension, tricuspid regurgitation and right-sided heart failure associated with hyperthyroidism: case report and review of the literature.

Hector F Lozano1, Charu N Sharma.   

Abstract

Primary pulmonary hypertension carries a grim prognosis, therefore, it is imperative that prior to reaching this diagnosis, a thorough search be made for all possible causes of pulmonary hypertension. An uncommon cause of pulmonary hypertension amenable to treatment may occasionally be identified. This case report describes a young woman who presented with rapidly progressive right heart failure. Work up for the common secondary causes of pulmonary hypertension was negative, including, congenital intracardiac shunts, left-sided atrial or ventricular heart disease, left-sided valvular heart disease, disorders of the respiratory system including hypoxemia and pulmonary thromboembolic and venoocclusive disease, collagen vascular disease, portal hypertension, HIV infection as well as pulmonary hypertension secondary to drugs and toxins. The only concurrent illness identified was Graves disease. After treatment of hyperthyroidism there was complete resolution of the right heart failure, tricuspid regurgitation, and the pulmonary hypertension. Only a few cases of reversible pulmonary hypertension and right heart failure associated with hyperthyroidism have been reported worldwide. In these patients, the most striking feature has been the normalization of the cardiovascular findings after adequate treatment of hyperthyroidism. The exact reasons for the development of pulmonary hypertension in hyperthyroidism are unclear. Proposed mechanisms include high cardiac output-induced endothelial injury, increased metabolism of intrinsic pulmonary vasodilating substances resulting in elevated pulmonary vascular resistance, and autoimmune phenomenon. Hyperthyroidism should be included in the causes of secondary pulmonary hypertension and/or otherwise unexplained right heart failure. This is especially important because hyperthyroidism is a treatable entity and its cardiac manifestations may be completely reversible.

Entities:  

Mesh:

Year:  2004        PMID: 15476566     DOI: 10.1097/01.crd.0000137259.83169.e3

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  22 in total

1.  Neonatal thyrotoxicosis presenting as persistent pulmonary hypertension.

Authors:  Rawad Obeid; Vaneet Kumar Kalra; Prem Arora; Felix Quist; Kathleen C Moltz; Nitin Shashikant Chouthai
Journal:  BMJ Case Rep       Date:  2012-05-30

2.  Reversible pulmonary hypertension with unclear etiology associated with suspected viral infection.

Authors:  Hong Deok Kim; Kwang Jin Chun; Seonghoon Choi; Jung Rae Cho; Namho Lee; Min-Kyung Kang
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

Review 3.  Embolic risk in atrial fibrillation that arises from hyperthyroidism: review of the medical literature.

Authors:  Elie Traube; Neil L Coplan
Journal:  Tex Heart Inst J       Date:  2011

Review 4.  Cardiovascular involvement in patients with different causes of hyperthyroidism.

Authors:  Bernadette Biondi; George J Kahaly
Journal:  Nat Rev Endocrinol       Date:  2010-06-29       Impact factor: 43.330

5.  Prevalence of echocardiographic criteria for the diagnosis of pulmonary hypertension in patients with Graves' disease: before and after antithyroid treatment.

Authors:  J H Suk; K I Cho; S H Lee; H G Lee; S M Kim; T I Kim; M K Kim; Y K Shong
Journal:  J Endocrinol Invest       Date:  2011-03-07       Impact factor: 4.256

6.  Severe tricuspid regurgitation and isolated right heart failure due to thyrotoxicosis.

Authors:  Maria Bonou; Konstantinos M Lampropoulos; Maria Andriopoulou; Dimitrios Kotsas; John Lakoumentas; John Barbetseas
Journal:  Indian Heart J       Date:  2012-09-12

7.  The correlation between left ventricular failure and right ventricular systolic dysfunction occurring in thyrotoxicosis.

Authors:  Ji Yeon Hong; Dae-Gyun Park; Jong Jin Yoo; Seung Min Lee; Min-Kwan Kim; Sung Eun Kim; Jun-Hee Lee; Kyoo-Rok Han; Dong-Jin Oh
Journal:  Korean Circ J       Date:  2010-06-29       Impact factor: 3.243

Review 8.  Thyrotoxic cardiac disease.

Authors:  Peter Dahl; Sara Danzi; Irwin Klein
Journal:  Curr Heart Fail Rep       Date:  2008-09

9.  Graves' disease--familiar foe, unfamiliar face.

Authors:  Sadishkumar Kamalanathan; Karthik Balachandran; Gobu Packirisamy; Abdoul Hamide
Journal:  BMJ Case Rep       Date:  2012-08-01

10.  Atypical clinical manifestations of graves' disease: an analysis in depth.

Authors:  Mohamed Osama Hegazi; Sherif Ahmed
Journal:  J Thyroid Res       Date:  2011-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.